Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06397027
Title	A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
Recruitment	Not yet recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	M.D. Anderson Cancer Center
Indications	acute biphenotypic leukemia acute lymphoblastic leukemia acute myeloid leukemia mixed phenotype acute leukemia with MLL rearranged
Therapies	Azacitidine + Venetoclax + Ziftomenib
Age Groups:	adult \| child
Covered Countries	USA